FDA Issues Warning Over Avandia Amid Outcry

Law360, New York (May 21, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration has issued a safety warning on Avandia, concerned that the popular diabetes drug significantly boosts the risk of heart attack and heart-related deaths.

On Monday, the FDA tossed out a stiff caution regarding the GlaxoSmithKline medication, which is primarily used to treat type 2 diabetes.

“Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia,” the statement said.

The FDA was quick...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.